Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001387239 | SCV001587804 | pathogenic | Glanzmann thrombasthenia | 2020-08-14 | criteria provided, single submitter | clinical testing | Loss-of-function variants in ITGA2B are known to be pathogenic (PMID: 21917754). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with ITGA2B-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly418Alafs*13) in the ITGA2B gene. It is expected to result in an absent or disrupted protein product. |